CDC to Withdraw Emergency Use Authorization for RT PCR Test Because It Cannot Distinguish Between SARS-CoV-2 and the Flu

boudica.us

CDC to Withdraw Emergency Use Authorization for RT PCR Test Because It Cannot Distinguish Between SARS-CoV-2 and the Flu
by Brian Shilhavy
Editor, Health Impact News

The CDC quietly announced last week that it was withdrawing its request to the FDA for Emergency Use Authorization (EUA) of the 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2.

Most of the public is probably unaware that similar to the current COVID-19 injections that are not yet approved by the FDA, but only given Emergency Use Authorization, so too the hundreds of diagnostic tests that supposedly detect COVID-19 are also NOT approved by the FDA, but only authorized via an EUA.

What is the reason the CDC is withdrawing its EUA request for the Real-Time RT-PCR Diagnostic Panel?

In preparation for this change, CDC recommends clinical laboratories and testing sites that have been…

View original post 337 more words

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s